Higgins K - Search Results

1

Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.

Empig C, Kenner JR, Perret-Gentil M, Youree BE, Bell E, Chen A, Gurwith M, Higgins K, Lock M, Rice AD, Schriewer J, Sinangil F, White E, Buller RM, Dermody TS, Isaacs SN, Moyer RW. Empig C, et al. Among authors: higgins k. Vaccine. 2006 Apr 24;24(17):3686-94. doi: 10.1016/j.vaccine.2005.03.029. Vaccine. 2006. PMID: 16430997

2

Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.

Balasubramanian P, Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell AJ, Haigwood NL, Sinangil F, Higgins KW, Liu L, Li L, Nyambi P, Gorny MK, Totrov M, Nadas A, Kong XP, Zolla-Pazner S, Hioe CE. Balasubramanian P, et al. Among authors: higgins kw. Vaccine. 2017 Mar 7;35(10):1464-1473. doi: 10.1016/j.vaccine.2016.11.107. Epub 2017 Feb 6. Vaccine. 2017. PMID: 28185743 Free PMC article.

3

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials.

Balasubramanian P, Williams C, Shapiro MB, Sinangil F, Higgins K, Nádas A, Totrov M, Kong XP, Fiore-Gartland AJ, Haigwood NL, Zolla-Pazner S, Hioe CE. Balasubramanian P, et al. Among authors: higgins k. Sci Rep. 2018 Jan 11;8(1):542. doi: 10.1038/s41598-017-18863-0. Sci Rep. 2018. PMID: 29323175 Free PMC article.

4

Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine.

Meza G, Expósito A, Royo JL, Ruiz-García C, Sánchez-Arcas B, Marquez FJ, Gómez-Vidal MA, Omar M, Sinangil F, Higgins K, Forthal D, Real LM, Caruz A. Meza G, et al. Among authors: higgins k. AIDS. 2020 Jan 1;34(1):25-32. doi: 10.1097/QAD.0000000000002401. AIDS. 2020. PMID: 31634193 Clinical Trial.

5

Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1.

O'Hagan DT, Ugozzoli M, Barackman J, Singh M, Kazzaz J, Higgins K, Vancott TC, Ott G. O'Hagan DT, et al. Among authors: higgins k. Vaccine. 2000 Mar 6;18(17):1793-801. doi: 10.1016/s0264-410x(99)00522-8. Vaccine. 2000. PMID: 10699327

6

Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.

Penezina O, Krueger NX, Rodriguez-Chavez IR, Busch MP, Hural J, Kim JH, O'Connell RJ, Hunter E, Aboud S, Higgins K, Kovalenko V, Clapham D, Crane D, Levin AE; HIV Selectest Study Group. Penezina O, et al. Among authors: higgins k. Clin Vaccine Immunol. 2014 Mar;21(3):391-8. doi: 10.1128/CVI.00748-13. Epub 2014 Jan 8. Clin Vaccine Immunol. 2014. PMID: 24403525 Free PMC article.

7

Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies.

Haigwood NL, Shuster JR, Moore GK, Lee H, Skiles PV, Higgins KW, Barr PJ, George-Nascimento C, Steimer KS. Haigwood NL, et al. Among authors: higgins kw. AIDS Res Hum Retroviruses. 1990 Jul;6(7):855-69. doi: 10.1089/aid.1990.6.855. AIDS Res Hum Retroviruses. 1990. PMID: 2390335

8

Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.

el-Amad Z, Murthy KK, Higgins K, Cobb EK, Haigwood NL, Levy JA, Steimer KS. el-Amad Z, et al. Among authors: higgins k. AIDS. 1995 Dec;9(12):1313-22. doi: 10.1097/00002030-199512000-00003. AIDS. 1995. PMID: 8605050

9

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.

Haigwood NL, Nara PL, Brooks E, Van Nest GA, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS. Haigwood NL, et al. Among authors: higgins kw. J Virol. 1992 Jan;66(1):172-82. doi: 10.1128/JVI.66.1.172-182.1992. J Virol. 1992. PMID: 1727480 Free PMC article.

10

Maternal monoclonal antibody to the V3 loop alters specificity of the response to a human immunodeficiency virus vaccine.

Jelonek MT, Maskrey JL, Steimer KS, Potts BJ, Higgins KW, Keller MA. Jelonek MT, et al. Among authors: higgins kw. J Infect Dis. 1996 Oct;174(4):866-9. doi: 10.1093/infdis/174.4.866. J Infect Dis. 1996. PMID: 8843232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

655 results

Search Page